Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.

European journal of clinical microbiology ·Vol. 5 ·No. 2 ·1986-04-00 ·Pages 248-51

Mehtar S, Drabu Y, Blakemore P

Abstract

暂无摘要

MeSH Terms

Anti-Bacterial Agents/therapeutic use Bacterial Infections/drug therapy,microbiology Bone Diseases/drug therapy,microbiology Catheters, Indwelling Ciprofloxacin Drug Evaluation Drug Resistance, Microbial Enterobacteriaceae Infections/drug therapy Gentamicins/pharmacology Gram-Negative Bacteria/drug effects Humans Microbial Sensitivity Tests Prospective Studies Pseudomonas Infections/drug therapy Quinolines/therapeutic use Urinary Tract Infections/drug therapy,microbiology

Chemicals

Anti-Bacterial Agents Gentamicins Quinolines Ciprofloxacin

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Mehtar S

Drabu Y

Blakemore P

References (3)

3 references, click to expand

Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin.
J Antimicrob Chemother. 1985 Nov;16(5):667-9 PMID: 2934363
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
J Antimicrob Chemother. 1985 May;15(5):551-8 PMID: 3159712
Mutational resistance to 4-quinolone antibacterial agents.
Eur J Clin Microbiol. 1984 Aug;3(4):347-50 PMID: 6237904

Article Info

Journal

European journal of clinical microbiology

Abbr.

Eur J Clin Microbiol

ISSN

0722-2211

DOI

10.1007/BF02014001

Published

1986-04-00

Pages

248-51

Language

English

Region

Germany

NLM ID

8219582

Subset

External Links

PubMed source DOI: 10.1007/BF02014001

Analysis Services

Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.

Contact

WeChat Official Account